Largest Swiss (SMI) Pharmaceuticals & Biotech Stocks by Market Cap

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Nov 18, 2025

Discover large cap Swiss Pharmaceuticals & Biotech companies that are on the SMI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ROG Roche Holding	CHF 306.70	6.2%	22.4%	CHF 262.7b	CHF 304.50	PE27.7x	E12.5%	3.2%
NOVN Novartis	CHF 102.00	-2.0%	12.0%	CHF 195.7b	CHF 103.65	PE17x	E6.5%	3.0%
LONN Lonza Group	CHF 529.20	-4.3%	3.0%	CHF 37.2b	CHF 677.55	PE50.7x	E20.5%	0.8%
GALD Galderma Group	CHF 146.00	-3.0%	69.9%	CHF 34.7b	CHF 150.31	PE114.7x	E31.0%	0.09%
SDZ Sandoz Group	CHF 53.88	-1.4%	35.6%	CHF 23.2b	CHF 51.64	PE127.8x	E29.8%	1.0%
DESN Dottikon ES Holding	CHF 305.00	-2.6%	33.5%	CHF 4.2b	CHF 357.63	PE39.9x	S12.7%	0%
BANB Bachem Holding	CHF 48.72	-5.7%	-27.4%	CHF 3.7b	CHF 74.69	PE27.2x	E16.9%	1.7%
SFZN Siegfried Holding	CHF 69.30	-9.5%	-37.3%	CHF 3.0b	CHF 110.07	PE19.7x	E11.0%	0.5%
TECN Tecan Group	CHF 133.60	-3.6%	-35.8%	CHF 1.7b	CHF 202.48	PE26.9x	E16.2%	2.2%
KURN Kuros Biosciences	CHF 26.88	-0.6%	18.7%	CHF 1.1b	CHF 32.80	PS10.2x	E60.9%	n/a
SKAN SKAN Group	CHF 46.30	-6.9%	-34.6%	CHF 1.0b	CHF 74.00	PE64.4x	E31.6%	0.9%
COPN Cosmo Pharmaceuticals	CHF 64.30	-0.9%	2.9%	CHF 1.0b	CHF 87.46	PE18.5x	E35.2%	3.0%
IDIA Idorsia	CHF 3.17	0.8%	337.2%	CHF 791.7m	CHF 2.00	PS3.4x	E32.3%	n/a
PPGN PolyPeptide Group	CHF 21.95	-8.7%	-16.5%	CHF 724.2m	CHF 34.35	PS2.1x	E65.3%	0%
BSLN Basilea Pharmaceutica	CHF 46.95	1.8%	18.1%	CHF 576.9m	CHF 90.78	PE7.9x	E-25.4%	0%
NWRN Newron Pharmaceuticals	CHF 15.80	10.6%	125.7%	CHF 315.4m	CHF 18.09	PE13.5x	E45.2%	n/a
SANN Santhera Pharmaceuticals Holding	CHF 10.28	-3.7%	23.9%	CHF 137.4m	CHF 30.00	PS2.8x	S48.7%	n/a
BIOV BioVersys	CHF 22.20	-19.3%	n/a	CHF 129.8m	CHF 60.00	PS99.2x	E-13.3%	n/a
MOLN Molecular Partners	CHF 3.31	6.6%	-32.6%	CHF 123.6m	CHF 9.25	PB1.3x	E-7.5%	n/a
XLS Xlife Sciences	CHF 16.60	-11.5%	-36.2%	CHF 95.7m	n/a	PE3.1x	n/a	n/a
CURN Curatis Holding	CHF 12.20	-2.8%	-22.8%	CHF 60.9m	CHF 84.50	n/a	n/a	n/a
RLF Relief Therapeutics Holding	CHF 2.60	-13.0%	-43.7%	CHF 32.7m	n/a	PS8.1x	n/a	n/a
ADXN Addex Therapeutics	CHF 0.057	-7.8%	-3.1%	CHF 8.3m	n/a	PS49.6x	S72.1%	n/a